Many firms on back foot due to US regulatory woes

It has been a mixed bag in terms of performance of pharma stocks in the last one year. Jubilant Life, Biocon and Caplin Point...

Granules to invest $20 mn in US subsidiary, Q3 net up 34% at Rs....

The company Board of Granules India Ltd has announced its move to invest $20 million in its wholly-owned subsidiary Granules Pharmaceulticals Inc. The company registered...